If you are struggling with a late-stage or complex form of cancer, Envita Medical Center and our proprietary oncology
technology may be the alternative solution you have been looking for. Envita is a Center of Excellence for precision
oncology and we are extremely familiar with the problems many patients face when pursuing cancer treatment. We know
that there is a better way to treat cancer and for the last 20 years we have been using personalized genetically
driven therapies to give our patients the best chance to respond favorably. In that time, we have developed many
advanced forms of treatment and chemotherapy including a state-of-the-art chemotherapy program we call GTFC or
Genetically Targeted Fractionated Chemotherapy.
Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from
person to person and should not be expected.
GTFC is our proprietary form of low-dose fractionated chemotherapy that can hit up to 7-10 genetic biomarkers and
mechanisms of tumor kill at once, something traditional chemotherapy simply cannot do. Furthermore, GTFC is
specifically designed to ensure that the majority of our patients experience minimal side-effects due to the
utilization of metronomic/low dosing. Through cutting-edge technology, we can precision target your cancer treatment
and provide chemotherapy that goes far beyond what most other clinics in the nation can provide. GTFC is uniquely
designed for each individual patient and is created in our in-house pharmacy ensuring that each treatment is
personalized and customized to the patient’s genetic targets.
Traditional chemotherapy is a taxing and destructive treatment that can be as harmful as the cancer it is meant to
treat when not properly targeted, at Envita we take a more advanced approach by combining GTFC with research-based
natural intravenous therapies, immunotherapies, and many other world-class treatments to provide a multifaceted
approach to treating cancer.
Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from
person to person and should not be expected.
GTFC and the NCCN
We believe Genetically Targeted Fractionated Chemotherapy to be the future of personalized cancer treatment. The
current standard approach to oncology prescribes chemotherapies based on tissue stage and location derived from the
NCCN guidelines. The NCCN (National Comprehensive Cancer Network) is defined as an alliance of 28 cancer centers
aiming to use a multidisciplinary team approach to patient care in order to help select the best treatment options for
a specific type and stage of cancer. However, these regimens are collated from data and clinical information taken
from large clinical trials that try to find the best treatment for the largest percentage of the population with the
same type and stage of cancer. Unfortunately, using this method alone is a flawed and outdated approach for
establishing cancer treatment options in our clinical opinion. Fortunately, Envita goes beyond the NCCN guidelines by
personalizing care for our patients based on advanced cancer genetic profiles. The genetic testing offered at Envita
for our GTFC process is far more detailed than other common cancer genetic profiles that are commonly available. The
advanced genetic profiles offered to our patients provide an advantage to potentially achieve more accurate and
targeted treatments, especially when other treatment options have failed the patient. Envita Medical Center has been
specializing in treating late-stage cancer for nearly 20 years. We base our treatments on patient specific advanced
genetic targets, molecular profiles, and biomarkers, giving our patients the best chances to achieve remission. The
GTFC process starts with great testing, but that is just the beginning to our process.
Next-Generation Personalized Genetic Information
Next-generation personalized genetic information is the bases for GTFC and that means identifying biomarkers that we
can target during your treatment. For those who do not know, biomarkers and other molecular targets are gathered
from your metastasized cancerous cells. These metastatic cells contain valuable information that we use to, among
other things, determine what chemotherapy agents and integrative agents that will work best for each specific
patient. We utilize cutting-edge technology to gather the necessary genetic information in a non-invasive and
efficient way. Instead of doing an aggressive tumor biopsy which can provide outdated data, we use circulating cancer
cells, and free-floating DNA because they represent the most current form of your ever-changing disease.
Circulating cancer cells can be gathered through a simple blood draw and genetic information can be updated throughout
treatment to evaluate progress and reassess therapy to keep the protocol dynamic. We gather your circulating cancer
cells and other genetic and nutritional information to perform intensely in-depth testing to get a cornucopia of data
on you and your cancer. This data becomes the driving force behind how we build a personalized treatment protocol for
you. Our proprietary testing is among the best in the nation and our ability to identify, track, and modulate the
genetic factors of your cancer is second to none. In our opinion, our experience and advanced methods makes us one of
the best treatment centers in the nation for late-stage and complex cancers.
With up-to-date genetic profiles on you and your cancer, we design GTFC to use the chemotherapy agents that are
scientifically found to be best for combatting your unique cancer. We test your cancer cells against a multitude of
different chemotherapy drugs to find the medications that are the most effective at hitting your cancer cell
biomarkers. Cancer cell antigen biomarkers are the gate-keepers of the cell and finding the chemotherapies that are
best suited to target your cancer cell antigen biomarkers is how the chemotherapy agent is going to target and
infiltrate your cancerous cells. By matching the chemotherapy to your cancer antigen biomarkers, we improve the
ability to target the cancerous cells and ignore healthy cells. With this information we can utilize our in-house
pharmacy Vertisis Custom Pharmacy to create a GTFC that is custom compounded to utilize the most efficacious
chemotherapy based on your cancer’s genetic targets. This is combined with a multifaceted protocol that uses
genetically targeted natural medicines, immunotherapies, and epigenetic factors.
GTFC's Targeting Method
Targeting our care is the key to properly attacking your cancer and it is meant to stack the odds in favor of our
patients and help overcome multidrug resistance (MDR). We use many different types of biomarkers to identify and
target your cancer. We look at cancer antigen biomarkers, metabolic biomarkers, epigenetic biomarkers (miRNA), genetic
biomarkers, immunotherapy markers and chromosomal biomarkers to guide and genetically target our personalized
treatment protocols and GTFC. We found clinically that genetically targeted care is a much more effective and precise
approach to treating cancer and, in concert with therapeutic windows induced by natural and integrative medicines, it
allows us to focus care and use fractionated doses of chemo agents that are far less than the normal doses used in
standard chemotherapy. The standardized method of chemotherapy uses the maximum therapeutic dose which is a fancy way
of saying they give you as much poison as they can in hopes that it kills the cancer cells before it harms you. Envita
sees the obvious flaw in this method and we designed GTFC to be precise and effective while reduced damage to healthy
cells. By utilizing fractionated doses and combining that with targeted natural therapies, immune recovery, smart
drugs, and phytotherapeutics we remove many of the major side-effects normally experienced during chemotherapy. We
work to make patients therapy as comfortable and effective as possible while undoing the negative repercussions from
Furthermore, these microdoses allow us to hit many more biomarkers and mechanisms of tumor kill at once than normal
chemotherapy in addition to decreasing the major side-effects caused by chemotherapy agents. Our method is so precise
and effective we do not need the maximum therapeutic dose to treat cancer. We can take microdoses of multiple chemo
agents at once and combine them in our in-house pharmacy Vertisis Custom Pharmacy to produce a customized medication
designed, combined, and produced to combat your unique cancer. We hit from 7-10 biomarkers at once and increase the
frequency of treatment to try and remove cancers ability to resist treatment.
GTFC’s Superior Absorption
The final component of GTFC is increased absorption. Normal intravenous chemotherapy treatment only gets an estimated
4-5% of the agents absorbed into the cancerous cells, but at Envita our goal is to get closer to a 100% absorption
into cancerous cells. Envita Medical Center uses cutting-edge natural therapies and techniques to increase the
absorption of chemotherapy during GTFC. We have been very successful using these techniques in the past but Envita’s
goal is for a complete 100% absorption while protecting healthy cells and that is why in some cases we utilize an
intratumoral GTFC that allows for image guided injections of these genetic and immunologic drugs directly into the
tumor. In cancers that have very fibrous and dense tissues around tumors we deploy a combination of cryoablation and
intra-tumor deployment of GTFC. This allows for an immediate kill at the tumor level to help our patients. GTFC is an
exciting advanced approach to potentially achieve better cancer outcomes for our patients. Envita is constantly
researching and improving our techniques to give our patients that greatest chance to respond to care. That is why we
developed GTFC and that is why we continue to refine and grow our tools for fighting against cancer. The vast majority
of our patients are always impressed and excited to see the options Envita can provide, as well as to learn why their
previous treatment plans didn’t respond as well as they had hoped. Our patients are excited to have a world-class
treatment plan where they can feel confident about their care.
Envita Medical Center has been treating late-stage and complex cancers for nearly 20 years and GTFC has been
instrumental in providing our patients the most up to date and effective care. We know the struggles and problems of
high-dose and protocol-driven chemotherapy treatments and we are fighting to provide as many patients as we can relief
from those shortcomings. GTFC is a highly specialized method for treating cancer and we believe it is the future of
personalized integrative cancer treatment. If you are looking for a better approach to treating you or your loved
one’s cancer, please contact our Patient Care Coordinators at 866-830-4576 and learn more about our treatment options.
 Smith, A.J., J. Oertle, and D. Prato, Genetically Targeted Fractionated Chemotherapy. Journal of Cancer
Therapy, 2015. Vol.06No.02: p. 17.
 Arnold, K., MEMORANDUM FOR: Science Writers and Editors on the Journal Press List: Biomarker for Esophageal
Cancer Found in Bloodstream. Journal of the National Cancer Institute, 2000. 92(22): p. 1787b-1787.
 Ludwig, J.A. and J.N. Weinstein, Biomarkers in Cancer Staging, Prognosis and Treatment Selection. Nature
Reviews Cancer, 2005. 5: p. 845
To better understand our unique approach to cancer treatment:
Envita Medical Center Continues to Be Fully Operational During the COVID-19 Outbreak
We at Envita Medical Center do not have the typical corporate response to the COVID-19 pandemic. For the last
20 years, we have been leaders in the field of advanced integrative medicine and immunotherapy. We are not
simply taking precautions but providing prophylactic support for our patients' immune systems against viral and
bacterial infections. Our aim is to keep our patients and staff in optimal health with stronger immune systems.
With the country issuing stay-at-home orders, cancer patients with late-stage diagnoses do not have the luxury
to wait weeks or months for this pandemic to pass before seeking treatment. Cancer is an ever-changing disease
that needs immediate and targeted treatment options to prevent further advancement and complications. Having the
appropriate immunotherapy options available to our patients makes all the difference with how the lungs and body
respond to infection, especially aggressive respiratory viruses.
At Envita Medical Center, your health, immunity, safety, and healing are the highest priority to us. We are not
a community hospital; patients are carefully screened and receive treatment from us for weeks or months at a
time (maintaining the same community). We want to assure you that our team of physicians and nurses are up to
date with the most current COVID-19 research and data. In fact, we have been asked to share our strategies with
members of The White House and major hospitals around the country to provide immunotherapy protocols to aid in
the prevention and treatment of COVID-19 for patients and first responders.
Please review the protective measures Envita has put in place to protect our patients and staff:
We are actively and prophylactically treating our patients and staff with antiviral immune protective
measures to maintain strong immune systems and reduce the risk of infection.
We are actively monitoring where incoming patients and caregivers have traveled in the past 60 days and if
they have been experiencing any symptoms. However, due to the many asymptomatic carriers, we treat all our
patients as though they have weak immunity and are at risk for infections.
We have put in place a telemedicine platform for our patients to be assessed and tested before coming to
Envita to receive treatment.
All active patients and deemed medically necessary caregivers are provided protective N95 masks to wear
throughout the treatment area and center.
We have an array of treatments that are designed to fight infection, support the immune system, and promote
respiratory health that are being used prophylactically.
The Envita team is providing routine cleans with peroxide wipes and CaviWipes before and after each patient
throughout the day with protective masking and gloves.
Our hospital certified cleaning crew performs nightly cleaning with medical grade products and
All Envita team is wearing protective N95 masks as an added layer of protection.
We have a top-of-the-line HEPA air purification system with nightly ozone purification and multiple HEPA
filters throughout the entire facility.
We have moved all non-essential personnel form our corporate offices to work-from-home, however, our
pharmacy team continues to supply medications to thousands of doctors across the country who are treating and
helping with COVID-19.
We have procured medication and supplies for many months to ensure our team does not run short on any
medication, supplies, or immunotherapies.
When being faced with challenges like these, it is important to realize that Envita Medical Center
is one of the safest places you can be during this pandemic because we are taking all the necessary precautions
to ensure our patients continue to receive the lifesaving treatments they need to help aid in overcoming
late-stage cancer and complex infectious diseases like debilitating Lyme disease. We are here for you, our
patients, and may God bless you on your journey to healing. If you have any questions, please do not hesitate to
reach out to Envita Medical Center at 866-830-4576, we have trained professionals standing by
to help guide you on the path toward healing.
Open COVID-19 Information Popup
Envita Medical Center continues to be fully operational during the COVID-19 outbreak